ATE283277T1 - Verfahren zur entfernung von viren aus proteinlösungen mittels nanofiltration - Google Patents

Verfahren zur entfernung von viren aus proteinlösungen mittels nanofiltration

Info

Publication number
ATE283277T1
ATE283277T1 AT98908308T AT98908308T ATE283277T1 AT E283277 T1 ATE283277 T1 AT E283277T1 AT 98908308 T AT98908308 T AT 98908308T AT 98908308 T AT98908308 T AT 98908308T AT E283277 T1 ATE283277 T1 AT E283277T1
Authority
AT
Austria
Prior art keywords
viruses
nanofiltration
removal
log
protein solutions
Prior art date
Application number
AT98908308T
Other languages
English (en)
Inventor
Harry Hiemstra
Hart Hendricus Gerardus Jo Ter
Nijs Ingrid Margareth Prins-De
Pieter Johannes Hoek
Jan Over
Original Assignee
Sanquin Bloedvoorziening
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26146172&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE283277(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanquin Bloedvoorziening filed Critical Sanquin Bloedvoorziening
Application granted granted Critical
Publication of ATE283277T1 publication Critical patent/ATE283277T1/de

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14—Ultrafiltration; Microfiltration
    • B01D61/145—Ultrafiltration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Water Supply & Treatment (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
AT98908308T 1997-02-24 1998-02-23 Verfahren zur entfernung von viren aus proteinlösungen mittels nanofiltration ATE283277T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97200533A EP0860444A1 (de) 1997-02-24 1997-02-24 Methode zur Entfernung von Viren aus Proteinlösungen
NL1005332 1997-02-24
PCT/NL1998/000108 WO1998037086A1 (en) 1997-02-24 1998-02-23 Method for removing viruses from protein solution by nanofiltration

Publications (1)

Publication Number Publication Date
ATE283277T1 true ATE283277T1 (de) 2004-12-15

Family

ID=26146172

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98908308T ATE283277T1 (de) 1997-02-24 1998-02-23 Verfahren zur entfernung von viren aus proteinlösungen mittels nanofiltration

Country Status (6)

Country Link
EP (2) EP0860444A1 (de)
AT (1) ATE283277T1 (de)
DE (1) DE69827787T2 (de)
DK (1) DK0979237T3 (de)
ES (1) ES2229481T3 (de)
WO (1) WO1998037086A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772381B1 (fr) † 1997-12-15 2001-06-08 Lab Francais Du Fractionnement Procede de preparation par filtration d'une solution de facteur viii securisee viralement
US7544500B2 (en) * 1999-11-13 2009-06-09 Talecris Biotherapeutics, Inc. Process for the production of a reversibly inactive acidified plasmin composition
US6355243B1 (en) 1999-11-13 2002-03-12 Bayer Corporation Method of thrombolysis by local delivery of active plasmin
EP1250929A4 (de) * 1999-12-20 2004-12-29 Mitsubishi Pharma Corp MITTELS PORöSER MEMBRAN BEHANDELTE, VIREN-FREIE PLASMAPROTEIN-VERBINDUNG UND DEREN HERSTELLUNGSPROZESS
ES2214967B1 (es) 2003-03-06 2005-06-16 Probitas Pharma, S.A Procedimiento para la eliminacion de virus en soluciones de fibrinogeno y fibrinogeno obtenido por dicho procedimiento.
WO2004089402A1 (ja) * 2003-04-09 2004-10-21 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute アルブミン製剤の製造方法
FR2861395B1 (fr) * 2003-10-23 2006-02-17 Lab Francais Du Fractionnement Facteur viii viralement securise a faible teneur en multimeres superieurs
EP2275432A1 (de) * 2003-12-01 2011-01-19 Novo Nordisk Health Care AG Nanofiltration von Faktor VII Lösungen zur Entfernung von Viren
AU2012201036B2 (en) * 2003-12-01 2014-12-04 Novo Nordisk Health Care Ag Virus filtration of liquid factor VII compositions
EP1888208B1 (de) * 2004-10-21 2012-11-14 Statens Serum Institut Verfahren mit nanofiltrierung zum erhalnten eines vor infektierenden mitteln sicheren mbl-produkts
ES2775974T3 (es) * 2006-06-26 2020-07-28 Omrix Biopharmaceuticals Inc Eliminación de virus por nanofiltración
ES2298096B1 (es) 2008-01-08 2009-01-01 Grifols, S.A. Procedimiento para la obtencion de un concentrado de factor von willebrand o del complejo de factor viii/factor von willebrand y utilizacionde los mismos.
KR20160110544A (ko) 2008-06-04 2016-09-21 그리폴스 테라퓨틱스 인코포레이티드 플라스민의 제조를 위한 조성물, 방법 및 키트
US8158405B2 (en) 2008-06-30 2012-04-17 General Electric Company Process for concentrating and processing fluid samples
US8546127B2 (en) 2008-06-30 2013-10-01 General Electric Company Bacteria/RNA extraction device
US9206410B2 (en) 2009-03-03 2015-12-08 Grifols Therapeutics Inc. Compositions, methods and kits for preparing plasminogen and plasmin prepared therefrom
CN103814137A (zh) * 2011-09-06 2014-05-21 米迪缪尼有限公司 处理凝血因子的方法
CN112978859A (zh) * 2021-04-13 2021-06-18 莱特莱德(上海)技术有限公司 一种提取肝素加工废水中肠膜肽的方法
CN116983835B (zh) * 2023-09-28 2024-01-09 杭州华玮生物科技有限公司 一种高强度纤维素除病毒过滤膜及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9500724D0 (sv) * 1994-06-23 1995-02-24 Pharmacia Ab Filtrering
US5677162A (en) * 1995-05-01 1997-10-14 New York Blood Center, Inc. Method for activating prothrombin to thrombin

Also Published As

Publication number Publication date
DE69827787D1 (de) 2004-12-30
EP0860444A1 (de) 1998-08-26
EP0979237A1 (de) 2000-02-16
DK0979237T3 (da) 2005-04-04
DE69827787T2 (de) 2006-03-02
ES2229481T3 (es) 2005-04-16
WO1998037086A1 (en) 1998-08-27
EP0979237B1 (de) 2004-11-24

Similar Documents

Publication Publication Date Title
ATE283277T1 (de) Verfahren zur entfernung von viren aus proteinlösungen mittels nanofiltration
ATE346861T1 (de) Verfahren zur reinigung und isolierung von viren, aus pflanzenquellen
MX9701183A (es) Procedimiento de preparacion del virus gripal, antigenos obtenidos y sus aplicaciones.
KR100998158B1 (ko) 나노여과에 의해서 단백질 용액으로부터 바이러스를 분리제거하는 방법
JPH0660105B2 (ja) 血漿中の肝炎ウイルスの不活性化方法
AU5176701A (en) Process for removing protein aggregate and virus from a protein solution
DE69740002D1 (de) Tierzellen und verfahren für die replikation von influenza viren
PT88178A (pt) Metodo para a purificacao de virus da hepatite a
ATE327774T1 (de) Verwendung von strukturierten tiefenfiltern zur entfernung von viren
GB1488774A (en) Hepatitis b antigen and method of producing it
CA2169122A1 (en) Removal of viruses from protein solutions by ultrafiltration
EE05203B1 (et) Nukleiinhapete puhastamine
KR20020063597A (ko) 다공성막으로 처리되어 바이러스가 제거된 혈장 단백질조성물 및 그 제조 방법
DE60312002D1 (de) Verwendung eines clathratmodifizierers zur forderung des durchgangs von proteinen bei nanofiltration
JPH11286453A (ja) 紫外線照射によるタンパク質含有組成物のウイルス不活化処理方法
ATE452911T1 (de) Virensicherer faktor viii mit niedrigem gehalt an höheren multimeren
DE69324645D1 (de) Verfahren zur Herstellung von Hepatitis Antigenen und Impfstoffen
AU3252095A (en) Method of producing infection-free pharmaceutical preparations and/or foodstuffs from infectious material, particular material containing prions
ATE323184T1 (de) Verfahren zur herstellung von blutplasmaprodukten durch ausschluss von spenden mit hohen parvo-b19- virenkonzentrationen
SU975795A1 (ru) Способ концентрировани и очистки вирусных суспензий
CA2524246C (en) Process for producing albumin preparations comprising virus-removing filtration
JP2000319294A (ja) 生物由来高分子溶液精製方法
US20040000482A1 (en) Viral removal
DE69012903D1 (de) Verfahren zur herstellung und reinigung von hepatitis b-impfstoff.
Chang et al. Concentrating rotavirus and recombinant enhanced green fluorescent protein from E. coli using a temperature-sensitive hydrogel

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0979237

Country of ref document: EP

RZN Patent revoked